CLINICAL_TRIALS
trial_result
· 2018-12-27
Clinical Trial Update: A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer [Phase 2]
Summary
Phase 2 clinical trial of Kevetrin in ovarian cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innovation Pharmaceuticals, Inc. | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-12-27